PMID: 9533723Apr 9, 1998Paper

Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
E T RietschelA J Ulmer

Abstract

Surface structures of bacteria contribute to the microbial pathogenic potential and are capable of causing local and generalized inflammatory reactions. Among these factors, endotoxin and peptidoglycan are of particular medical importance. Both toxic bacterial polymers are now recognized to interact with the same cellular receptor, the CD14 molecule, which is expressed on different types of immune cells, in particular, monocytes/macrophages. The interaction between these bacterial activators and CD14 leads to the production of endogenous mediators such as tumor necrosis factor alpha, interleukin 1 (IL-1), and IL-6, which are ultimately responsible for phlogistic responses. The fact that CD14 recognizes not only endotoxin and peptidoglycan but also other glycosyl-based microbial polymers suggests that this cellular surface molecule represents a lectin.

References

Jul 1, 1992·Immunology Today·W A Lynn, D T Golenbock
Jan 1, 1990·Annual Review of Biochemistry·C R Raetz
Sep 21, 1990·Science·R R SchumannR J Ulevitch
Apr 1, 1985·European Journal of Biochemistry·C GalanosH Yoshimura
Feb 1, 1987·The Journal of Clinical Investigation·C F Nathan
Apr 1, 1995·The Journal of Experimental Medicine·R R Ingalls, D T Golenbock
Jan 1, 1993·European Journal of Immunology·T EspevikA Sundan
Apr 7, 1995·Science·W J ChristM A Mullarkey
Feb 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E T RietschelF Di Padova
Dec 1, 1993·European Journal of Biochemistry·K BrandenburgU Seydel
May 1, 1993·Infection·Y LermanY L Danon
Jul 1, 1996·Journal of Leukocyte Biology·M J Sweet, D A Hume
Jan 1, 1996·Current Topics in Microbiology and Immunology·E T RietschelR R Schumann
Sep 20, 1996·The Journal of Biological Chemistry·D GuptaR Dziarski

❮ Previous
Next ❯

Citations

Jul 4, 2012·Apoptosis : an International Journal on Programmed Cell Death·Syeda T TowhidFlorian Lang
Oct 31, 2000·Nutrition·W Langhans
Jul 30, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Lise MoesbyChristina Nielsen
Jul 20, 2007·The Proceedings of the Nutrition Society·Wolfgang Langhans
Sep 8, 2001·Mediators of Inflammation·D MuhvićD Rukavina
Jun 14, 2002·Mediators of Inflammation·Ines Mrakovcić-SutićDaniel Rukavina
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L HornJ B Zabriskie
May 12, 2011·Journal of Cardiovascular Pharmacology·Nga N TaYan Huang
Dec 19, 2000·Infection and Immunity·D A BouisM V Norgard
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·UNKNOWN Brazilian National Genome Project Consortium
Mar 30, 2013·International Journal of Medical Microbiology : IJMM·Majed AbedFlorian Lang
Jun 15, 2011·Biotechnology Advances·Francesco Peri, Matteo Piazza
Apr 2, 2011·Developmental and Comparative Immunology·Sebastian BoltañaSimon A Mackenzie
May 1, 2010·Pharmacology, Biochemistry, and Behavior·Thomas RiedigerThomas A Lutz
Jul 24, 2008·Biochemical and Biophysical Research Communications·Cynthia St HilaireKatya Ravid
Apr 24, 2007·The International Journal of Biochemistry & Cell Biology·Izabela M NitaSabina M Janciauskiene
Jul 30, 2014·Frontiers in Immunology·Theodoros Kelesidis
Jul 11, 2007·Journal of Endotoxin Research·Yukari FujimotoKoichi Fukase
Feb 18, 2017·International Journal of Molecular Sciences·Slawomir MichalakWojciech Kozubski
Oct 14, 2005·Chembiochem : a European Journal of Chemical Biology·Abhijit RoychowdhuryGeert-Jan Boons
May 13, 2011·Journal of Leukocyte Biology·Andrew Devitt, Lindsay J Marshall
Dec 1, 2005·Chembiochem : a European Journal of Chemical Biology·Hyi-Seung LeeGeert-Jan Boons
Jan 5, 2006·Organic & Biomolecular Chemistry·Seiichi InamuraKoichi Fukase
Aug 25, 2006·The Journal of Biological Chemistry·Mareike MuellerAndra B Schromm
Aug 22, 2014·American Journal of Physiology. Renal Physiology·David S HainsAndrew L Schwaderer
Nov 26, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A SediváH J Gabius
May 18, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Claudia RennemeierBeate E Kehrel
Jun 17, 2020·Experimental and Therapeutic Medicine·Junling LiuHui Wang
Apr 21, 2017·Frontiers in Immunology·Alexei ChristodoulidesTheodoros Kelesidis
Oct 1, 2001·Journal of Periodontology·Yuichi IshiharaJohn G Tew
Mar 20, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M YinR G Thurman
Jul 17, 1999·The American Journal of Physiology·T YangJ B Schnermann
Jul 17, 2019·Brain, Behavior, and Immunity·Léa ChaskielJan Pieter Konsman
May 22, 2007·Bioorganic & Medicinal Chemistry·Yanghui ZhangGeert-Jan Boons

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.